Diffuse Alveolar Hemorrhage as a Complication of Severe Bronchopulmonary Dysplasia: A Case Report

Xiaoying Zhao(Handan College), Jun Yuan(Jiangyin People's Hospital), X D Wang(Hospital of Hebei Province), Chang Chen(Tsinghua University), Xiaoqi Zhang(Nanjing Drum Tower Hospital), Wei Zheng

Archivos de Bronconeumología

February 21, 2025

10.1016/j.arbres.2025.02.005

Cited by 2

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2013|247

Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis

|BMC Cancer|2014|146

In Situ Synthesis of Natural Antioxidase Mimics for Catalytic Anti-Inflammatory Treatments: Rheumatoid Arthritis as an Example

|Journal of the American Chemical Society|2021|123